Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cavanagh

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Journal of Microbiology & Biology Education|August 4, 2020
Benefits of a College STEM Faculty Development Initiative: Instructors Report Increased and Sustained Implementation of Research-Based Instructional StrategiesMary F Durham, Oriana R Aragón, Meghan E Bathgate, et al.
The British Journal of Dermatology|April 14, 2019
Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidityK A Bain, E McDonald, F Moffat, et al.
Advanced Healthcare Materials|October 19, 2020
Effects of Polymer 3D Architecture, Size, and Chemistry on Biological Transport and Drug Delivery In Vitro and in Orthotopic Triple Negative Breast Cancer ModelsAmanda K Pearce, Akosua B Anane-Adjei, Robert J Cavanagh, et al.
Clinical Neurology and Neurosurgery|July 22, 2010
Who is referred to neurology clinics?--the diagnoses made in 3781 new patientsJ Stone, A Carson, R Duncan, et al.
Chempluschem|February 28, 2025
Enzymatic Synthesis of Functional PEGylated Adipate CopolymersEleni Axioti, Emily G Dixon, Thomas Jepras, et al.
Brain : a Journal of Neurology|September 10, 2009
Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up?Jon Stone, A Carson, R Duncan, et al.
Psychological Medicine|July 25, 2009
Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcomeM Sharpe, J Stone, C Hibberd, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 4, 2024
Multiple drug-delivery strategies to enhance the pharmacological and toxicological properties of Mefenamic acidClaudia Cristiano, Robert J Cavanagh, Valentina Cuzzucoli Crucitti, et al.
Translational Psychiatry|January 11, 2017
Decreased hippocampal translocator protein (18 kDa) expression in alcohol dependence: a [<sup>11</sup>C]PBR28 PET studyN J Kalk, Q Guo, D Owen, et al.
Biomaterials Science|April 5, 2022
Synthesis, characterisation and evaluation of hyperbranched <i>N</i>-(2-hydroxypropyl) methacrylamides for transport and delivery in pancreatic cell lines <i>in vitro</i> and <i>in vivo</i>Akosua B Anane-Adjei, Nicholas L Fletcher, Robert J Cavanagh, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Journal of Microbiology & Biology Education|August 4, 2020
Benefits of a College STEM Faculty Development Initiative: Instructors Report Increased and Sustained Implementation of Research-Based Instructional StrategiesMary F Durham, Oriana R Aragón, Meghan E Bathgate, et al.
The British Journal of Dermatology|April 14, 2019
Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidityK A Bain, E McDonald, F Moffat, et al.
Advanced Healthcare Materials|October 19, 2020
Effects of Polymer 3D Architecture, Size, and Chemistry on Biological Transport and Drug Delivery In Vitro and in Orthotopic Triple Negative Breast Cancer ModelsAmanda K Pearce, Akosua B Anane-Adjei, Robert J Cavanagh, et al.
Clinical Neurology and Neurosurgery|July 22, 2010
Who is referred to neurology clinics?--the diagnoses made in 3781 new patientsJ Stone, A Carson, R Duncan, et al.
Chempluschem|February 28, 2025
Enzymatic Synthesis of Functional PEGylated Adipate CopolymersEleni Axioti, Emily G Dixon, Thomas Jepras, et al.
Brain : a Journal of Neurology|September 10, 2009
Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up?Jon Stone, A Carson, R Duncan, et al.
Psychological Medicine|July 25, 2009
Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcomeM Sharpe, J Stone, C Hibberd, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 4, 2024
Multiple drug-delivery strategies to enhance the pharmacological and toxicological properties of Mefenamic acidClaudia Cristiano, Robert J Cavanagh, Valentina Cuzzucoli Crucitti, et al.
Translational Psychiatry|January 11, 2017
Decreased hippocampal translocator protein (18 kDa) expression in alcohol dependence: a [<sup>11</sup>C]PBR28 PET studyN J Kalk, Q Guo, D Owen, et al.
Biomaterials Science|April 5, 2022
Synthesis, characterisation and evaluation of hyperbranched <i>N</i>-(2-hydroxypropyl) methacrylamides for transport and delivery in pancreatic cell lines <i>in vitro</i> and <i>in vivo</i>Akosua B Anane-Adjei, Nicholas L Fletcher, Robert J Cavanagh, et al.
Pageof 12